Pub Date : 2026-03-12eCollection Date: 2026-01-01DOI: 10.1515/med-2025-1348
Sarah Monserrat Lomelí-Martínez, Melissa Martínez-Nieto, Ruth Rodríguez-Montaño, Mario Alberto Alarcón-Sánchez, Juan José Varela Hernández, Adrián Fernando Gutiérrez-Maldonado, Juan Carlos Gomez-Mireles, Christian Ramírez Sánchez, Erandis Dheni Torres-Sánchez
Introduction: This narrative review describes the scientific evidence on drug-induced gingival overgrowth (DIGO) in kidney transplant patients treated with immunosuppressive agents, particularly Cyclosporine A, focusing on its prevalence, pathogenetic mechanisms, and clinical management strategies.
Content: This study was conducted including PubMed, Scopus, and Web of Science, highlighting clinical studies and case reports.
Summary: DIGO is an oral complication in transplant patients treated with cyclosporine A, and its frequency may increase when combined with calcium channel blockers. However, tacrolimus has shown a lower incidence of DIGO compared with Cyclosporine A, making it a favorable therapeutic alternative in immunosuppressive regimens for renal transplant patients. Mycophenolate mofetil, despite being less directly linked to DIGO, can exacerbate gingival changes when combined with other immunosuppressants by promoting inflammation and connective tissue remodeling. Sirolimus is associated with a lower risk of DIGO compared with calcineurin inhibitors; however, some isolated cases have been reported, particularly in patients previously exposed to Cyclosporine A or when used in combination with calcium channel blockers. Management strategies include proper oral hygiene, dose adjustment or medication substitution, and, in some cases surgical intervention.
Outlook: The fundamental keys to reducing its incidence and severity are a personalized immunosuppressive regimen with a multidisciplinary approach.
摘要:本文综述了免疫抑制剂治疗肾移植患者药物性牙龈过度生长(DIGO)的科学证据,特别是环孢素A,重点介绍了其患病率、发病机制和临床管理策略。内容:本研究纳入PubMed、Scopus和Web of Science,重点介绍临床研究和病例报告。摘要:DIGO是环孢素A治疗移植患者的一种口腔并发症,与钙通道阻滞剂联合使用时其发生频率可能增加。然而,与环孢素a相比,他克莫司显示出较低的DIGO发生率,使其成为肾移植患者免疫抑制方案中较好的治疗选择。霉酚酸酯虽然与DIGO没有直接联系,但当与其他免疫抑制剂联合使用时,可通过促进炎症和结缔组织重塑而加剧牙龈变化。与钙调磷酸酶抑制剂相比,西罗莫司与较低的DIGO风险相关;然而,也有一些孤立病例的报道,特别是以前暴露于环孢素A或与钙通道阻滞剂联合使用的患者。管理策略包括适当的口腔卫生,剂量调整或药物替代,在某些情况下手术干预。展望:降低其发病率和严重程度的关键是采用多学科方法的个性化免疫抑制方案。
{"title":"Drug-induced gingival overgrowth in renal transplants patients.","authors":"Sarah Monserrat Lomelí-Martínez, Melissa Martínez-Nieto, Ruth Rodríguez-Montaño, Mario Alberto Alarcón-Sánchez, Juan José Varela Hernández, Adrián Fernando Gutiérrez-Maldonado, Juan Carlos Gomez-Mireles, Christian Ramírez Sánchez, Erandis Dheni Torres-Sánchez","doi":"10.1515/med-2025-1348","DOIUrl":"10.1515/med-2025-1348","url":null,"abstract":"<p><strong>Introduction: </strong>This narrative review describes the scientific evidence on drug-induced gingival overgrowth (DIGO) in kidney transplant patients treated with immunosuppressive agents, particularly Cyclosporine A, focusing on its prevalence, pathogenetic mechanisms, and clinical management strategies.</p><p><strong>Content: </strong>This study was conducted including PubMed, Scopus, and Web of Science, highlighting clinical studies and case reports.</p><p><strong>Summary: </strong>DIGO is an oral complication in transplant patients treated with cyclosporine A, and its frequency may increase when combined with calcium channel blockers. However, tacrolimus has shown a lower incidence of DIGO compared with Cyclosporine A, making it a favorable therapeutic alternative in immunosuppressive regimens for renal transplant patients. Mycophenolate mofetil, despite being less directly linked to DIGO, can exacerbate gingival changes when combined with other immunosuppressants by promoting inflammation and connective tissue remodeling. Sirolimus is associated with a lower risk of DIGO compared with calcineurin inhibitors; however, some isolated cases have been reported, particularly in patients previously exposed to Cyclosporine A or when used in combination with calcium channel blockers. Management strategies include proper oral hygiene, dose adjustment or medication substitution, and, in some cases surgical intervention.</p><p><strong>Outlook: </strong>The fundamental keys to reducing its incidence and severity are a personalized immunosuppressive regimen with a multidisciplinary approach.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20251348"},"PeriodicalIF":1.6,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12981914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147463250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-09eCollection Date: 2026-01-01DOI: 10.1515/med-2026-1399
Suleyman Sagir, Ugur Seker, Merve Pekince-Ozoner, Meral Yuksel, Gul Sahika Gokdemir, Seval Kaya, Mehmet Demir
Objectives: The study aimed to investigate the nephroprotective effects of visnagin on renal ischemia-reperfusion (I/R) injury and the role of M1/M2 macrophage polarization in this process.
Methods: Forty-two adult rats were divided into six groups: Control, Visnagin30 mg/kg, Visnagin60 mg/kg, I/R, I/R + Visnagin30 mg/kg, I/R + Visnagin60 mg/kg (n=7). Bilateral renal ischemia was induced by clamping for 25 min, followed by 2 h of reperfusion. Visnagin or vehicle was administered to the animals intraperitoneally 2 h before reperfusion. At the end of the study, kidney samples were collected for analysis of oxidative stress, inflammatory cytokines, apoptotic protein expression, and M1/M2 macrophage polarization.
Results: I/R injury increased malondialdehyde (MDA), chemiluminescence (CL), IL-1β, and IL-6 levels while decreasing glutathione (GSH) in renal tissue, indicating enhanced oxidative stress (p<0.001) and inflammation (p<0.05). Histopathological examination showed glomerular atrophy, tubular degeneration, and intertubular hemorrhage. Visnagin treatment at 60 mg/kg significantly reduced MDA, CL, and IL-1β levels, and increased GSH (p<0.05). Immunohistochemically, visnagin decreased Bax (p<0.001), caspase-3 (p<0.01), and TNF-α (p<0.01) expressions elevated by I/R injury. Furthermore, visnagin reversed I/R induced M1/M2 macrophage polarization (CD86↑, CD163↓), decreasing CD86 (p<0.05) and increasing CD163 immunodensity (p<0.05).
Conclusions: Visnagin treatment (60 mg/kg) exerts promising nephroprotective effects in renal I/R injury by reducing oxidative stress, inflammation, apoptosis, and modulating M1/M2 macrophage polarization.
{"title":"Nephroprotective effects of visnagin through modulation of macrophage polarization, oxidative stress, inflammation and apoptosis in renal I/R injury.","authors":"Suleyman Sagir, Ugur Seker, Merve Pekince-Ozoner, Meral Yuksel, Gul Sahika Gokdemir, Seval Kaya, Mehmet Demir","doi":"10.1515/med-2026-1399","DOIUrl":"https://doi.org/10.1515/med-2026-1399","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to investigate the nephroprotective effects of visnagin on renal ischemia-reperfusion (I/R) injury and the role of M1/M2 macrophage polarization in this process.</p><p><strong>Methods: </strong>Forty-two adult rats were divided into six groups: Control, Visnagin30 mg/kg, Visnagin60 mg/kg, I/R, I/R + Visnagin30 mg/kg, I/R + Visnagin60 mg/kg (n=7). Bilateral renal ischemia was induced by clamping for 25 min, followed by 2 h of reperfusion. Visnagin or vehicle was administered to the animals intraperitoneally 2 h before reperfusion. At the end of the study, kidney samples were collected for analysis of oxidative stress, inflammatory cytokines, apoptotic protein expression, and M1/M2 macrophage polarization.</p><p><strong>Results: </strong>I/R injury increased malondialdehyde (MDA), chemiluminescence (CL), IL-1β, and IL-6 levels while decreasing glutathione (GSH) in renal tissue, indicating enhanced oxidative stress (p<0.001) and inflammation (p<0.05). Histopathological examination showed glomerular atrophy, tubular degeneration, and intertubular hemorrhage. Visnagin treatment at 60 mg/kg significantly reduced MDA, CL, and IL-1β levels, and increased GSH (p<0.05). Immunohistochemically, visnagin decreased Bax (p<0.001), caspase-3 (p<0.01), and TNF-α (p<0.01) expressions elevated by I/R injury. Furthermore, visnagin reversed I/R induced M1/M2 macrophage polarization (CD86↑, CD163↓), decreasing CD86 (p<0.05) and increasing CD163 immunodensity (p<0.05).</p><p><strong>Conclusions: </strong>Visnagin treatment (60 mg/kg) exerts promising nephroprotective effects in renal I/R injury by reducing oxidative stress, inflammation, apoptosis, and modulating M1/M2 macrophage polarization.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261399"},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12965831/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147390594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-09eCollection Date: 2026-01-01DOI: 10.1515/med-2025-1373
JingXia Wang, QiaoQiao Kong, Jing Chen, HePing Xia, MaoLin Han, ChuangZhou Xie, Ning You
Objectives: This study assessed the relationship between glycated serum protein (GSP) and post-reflux swallow-induced peristaltic wave (PSPW) index and esophageal baseline impedance (BI) in patients with diabetes mellitus (DM) with gastroesophageal reflux disease (GERD).
Methods: General clinical data of patients in the DM and DM/GERD groups were compared. Multifactorial Logistic regression analyses were performed to screen for independent factors on GERD in DM patients, and odds ratio (OR) was calculated. The risk of GERD was assessed using a spline regression model constructed on the basis of GSP, PSPW and BI. Predictive efficacy was analyzed using Receiver operating curve (ROC) curve analysis.
Results: Statistically significant differences were found in TG, hs-CRP, GSP, PSPW, and BI between patients in the DM and DM/GERD groups. PSPW and BI (OR=0.99, p<0.01) were independent protective factors, and elevated GSP was an independent risk factor for the development of GERD. A linear relationship was validated between GSP and PSPW and BI and the prevalence risk of developing GERD in patients with DM, all with good predictive efficacy.
Conclusions: GSP, PSPW, and BI show significant correlations with the onset and progression of GERD in patients and all demonstrate good predictive efficacy. However, due to the small size of the patient cohort, the generalizability of these findings requires further validation.
{"title":"Exploring the link between glycated serum protein and esophageal metrics in diabetic GERD patients.","authors":"JingXia Wang, QiaoQiao Kong, Jing Chen, HePing Xia, MaoLin Han, ChuangZhou Xie, Ning You","doi":"10.1515/med-2025-1373","DOIUrl":"https://doi.org/10.1515/med-2025-1373","url":null,"abstract":"<p><strong>Objectives: </strong>This study assessed the relationship between glycated serum protein (GSP) and post-reflux swallow-induced peristaltic wave (PSPW) index and esophageal baseline impedance (BI) in patients with diabetes mellitus (DM) with gastroesophageal reflux disease (GERD).</p><p><strong>Methods: </strong>General clinical data of patients in the DM and DM/GERD groups were compared. Multifactorial Logistic regression analyses were performed to screen for independent factors on GERD in DM patients, and odds ratio (OR) was calculated. The risk of GERD was assessed using a spline regression model constructed on the basis of GSP, PSPW and BI. Predictive efficacy was analyzed using Receiver operating curve (ROC) curve analysis.</p><p><strong>Results: </strong>Statistically significant differences were found in TG, hs-CRP, GSP, PSPW, and BI between patients in the DM and DM/GERD groups. PSPW and BI (OR=0.99, p<0.01) were independent protective factors, and elevated GSP was an independent risk factor for the development of GERD. A linear relationship was validated between GSP and PSPW and BI and the prevalence risk of developing GERD in patients with DM, all with good predictive efficacy.</p><p><strong>Conclusions: </strong>GSP, PSPW, and BI show significant correlations with the onset and progression of GERD in patients and all demonstrate good predictive efficacy. However, due to the small size of the patient cohort, the generalizability of these findings requires further validation.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20251373"},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12965830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147390599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.1515/med-2025-1342
Yukun Liu, Xuan Zhao, Zhikai Xu, Qinxin Liu, Yuchang Wang
Background: Sepsis-induced myopathy (SIM)significantly contributes to long-term disability and mortality among sepsis survivors. A comprehensive understanding of both the molecular mechanisms and rehabilitation strategies is crucial for effective management.
Methods: A review of pertinent studies was conducted, focusing on the molecular pathogenesis, therapeutic strategies, and rehabilitation interventions for SIM, with particular attention to clinical and translational advancements.
Results: Current management strategies encompass infection control, modulation of inflammation, nutritional support, and structured rehabilitation programs, including early mobilization and physiotherapy. Emerging therapies that target inflammation, cellular protection, and regeneration - such as stem cell therapy and gene-editing techniques - demonstrate potential. Furthermore, advancements in personalized medicine, including genomics, transcriptomics, and individualized metabolic interventions, may further improve outcomes.
Conclusions: Optimizing both mechanistic and rehabilitation strategies is essential for enhancing functional recovery and quality of life in patients with SIM. An integrated clinical and molecular approach presents the most promising path forward. Keywords: sepsis-induced myopathy, sepsis.
{"title":"Beyond muscle weakness: pathogenesis of sepsis-induced myopathy and its management.","authors":"Yukun Liu, Xuan Zhao, Zhikai Xu, Qinxin Liu, Yuchang Wang","doi":"10.1515/med-2025-1342","DOIUrl":"10.1515/med-2025-1342","url":null,"abstract":"<p><strong>Background: </strong>Sepsis-induced myopathy (SIM)significantly contributes to long-term disability and mortality among sepsis survivors. A comprehensive understanding of both the molecular mechanisms and rehabilitation strategies is crucial for effective management.</p><p><strong>Methods: </strong>A review of pertinent studies was conducted, focusing on the molecular pathogenesis, therapeutic strategies, and rehabilitation interventions for SIM, with particular attention to clinical and translational advancements.</p><p><strong>Results: </strong>Current management strategies encompass infection control, modulation of inflammation, nutritional support, and structured rehabilitation programs, including early mobilization and physiotherapy. Emerging therapies that target inflammation, cellular protection, and regeneration - such as stem cell therapy and gene-editing techniques - demonstrate potential. Furthermore, advancements in personalized medicine, including genomics, transcriptomics, and individualized metabolic interventions, may further improve outcomes.</p><p><strong>Conclusions: </strong>Optimizing both mechanistic and rehabilitation strategies is essential for enhancing functional recovery and quality of life in patients with SIM. An integrated clinical and molecular approach presents the most promising path forward. Keywords: sepsis-induced myopathy, sepsis.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20251342"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.1515/med-2026-1387
Yang Bai, Zhe Wang, Chunling Zhang
Objectives: This meta-analysis evaluates Janus Kinase (JAK) inhibitors' efficacy and safety in large vessel vasculitis (LVV), encompassing Giant Cell Arteritis (GCA) and Takayasu's Arteritis (TAK).
Methods: Registered on PROSPERO (CRD42024575313), four databases were systematically searched for randomized controlled trials (RCTs) and observational studies. Outcomes included remission/relapse rates and adverse events, assessed with sensitivity/publication bias analyses.
Results: Five studies (107 patients: 65 GCA, 42 TAK) showed pooled 12-month remission rates of 80.1 % (95 % CI: 68.3-92.0), with subgroup rates of 87.3 % (GCA) and 69.6 % (TAK). Relapse rates were 11.3 % overall (2.5 % GCA vs. 22.9 % TAK). Adverse event-related discontinuation was 4.4 %, with subgroup rates of 4.0 % (GCA) and 4.2 % (TAK).
Conclusions: JAK inhibitors demonstrate favorable efficacy and safety in LVV.
{"title":"Janus Kinase inhibitors in the treatment of large vessel vasculitis: a systematic review and meta-analysis.","authors":"Yang Bai, Zhe Wang, Chunling Zhang","doi":"10.1515/med-2026-1387","DOIUrl":"10.1515/med-2026-1387","url":null,"abstract":"<p><strong>Objectives: </strong>This meta-analysis evaluates Janus Kinase (JAK) inhibitors' efficacy and safety in large vessel vasculitis (LVV), encompassing Giant Cell Arteritis (GCA) and Takayasu's Arteritis (TAK).</p><p><strong>Methods: </strong>Registered on PROSPERO (CRD42024575313), four databases were systematically searched for randomized controlled trials (RCTs) and observational studies. Outcomes included remission/relapse rates and adverse events, assessed with sensitivity/publication bias analyses.</p><p><strong>Results: </strong>Five studies (107 patients: 65 GCA, 42 TAK) showed pooled 12-month remission rates of 80.1 % (95 % CI: 68.3-92.0), with subgroup rates of 87.3 % (GCA) and 69.6 % (TAK). Relapse rates were 11.3 % overall (2.5 % GCA vs. 22.9 % TAK). Adverse event-related discontinuation was 4.4 %, with subgroup rates of 4.0 % (GCA) and 4.2 % (TAK).</p><p><strong>Conclusions: </strong>JAK inhibitors demonstrate favorable efficacy and safety in LVV.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261387"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lung cancer presents a major global public health challenge due to its high incidence and mortality rates, highlighting the urgent need for effective treatment strategies. Radiotherapy, a cornerstone in lung cancer treatment, faces significant limitations due to both intrinsic and acquired radioresistance in tumors. Recent researches have identified long non-coding RNAs (lncRNAs) as critical regulatory factors that significantly affect the radiosensitivity of lung cancer cells. These lncRNAs are involved in key biological processes, including DNA damage repair, apoptotic signaling, cell cycle progression, tumor microenvironment remodeling. This review comprehensively summarizes and discusses the molecular mechanisms by which lncRNAs influence radiosensitivity and assesses their potential as predictive biomarkers for radiotherapy. Additionally, it analyzes the potential of lncRNA-based intervention strategies to overcome radioresistance and enhance radiotherapy regimens. The goal is to provide a robust theoretical foundation for advancing precision radiotherapy in lung cancer. In summary, lncRNAs function as multidimensional regulators of lung cancer radiosensitivity and represent promising targets for radiosensitization in the precision medicine era.
{"title":"LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity.","authors":"Yuhan Chen, Jiajie Shi, Changcheng Qin, Shuhua Yang, Burong Hu, Junfang Yan","doi":"10.1515/med-2026-1379","DOIUrl":"https://doi.org/10.1515/med-2026-1379","url":null,"abstract":"<p><p>Lung cancer presents a major global public health challenge due to its high incidence and mortality rates, highlighting the urgent need for effective treatment strategies. Radiotherapy, a cornerstone in lung cancer treatment, faces significant limitations due to both intrinsic and acquired radioresistance in tumors. Recent researches have identified long non-coding RNAs (lncRNAs) as critical regulatory factors that significantly affect the radiosensitivity of lung cancer cells. These lncRNAs are involved in key biological processes, including DNA damage repair, apoptotic signaling, cell cycle progression, tumor microenvironment remodeling. This review comprehensively summarizes and discusses the molecular mechanisms by which lncRNAs influence radiosensitivity and assesses their potential as predictive biomarkers for radiotherapy. Additionally, it analyzes the potential of lncRNA-based intervention strategies to overcome radioresistance and enhance radiotherapy regimens. The goal is to provide a robust theoretical foundation for advancing precision radiotherapy in lung cancer. In summary, lncRNAs function as multidimensional regulators of lung cancer radiosensitivity and represent promising targets for radiosensitization in the precision medicine era.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261379"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06eCollection Date: 2026-01-01DOI: 10.1515/med-2026-1377
Sonja P Cekić, Dijana S Risimić, Maja M Simonović, Nikola M Stojanović, Aleksandra Ignjatović
Objectives: Diabetic retinopathy (DR) is a severe complication of diabetes mellitus (DM) leading to vision loss and blindness, which typically develops 12-20 years after the diagnosis of DM. Anxiety and depression frequently co-occur with chronic medical conditions like DM and DR, impacting their onset, course, and prognosis. This study aimed to examine the link between anxiety, depression, DR, and macular changes.
Methods: A cross-sectional study was conducted at the Clinic for Ophthalmology, University Clinical Center Niš, Serbia, involving 80 adult participants, naïve to psychiatric and invasive ophthalmological therapy, divided into two groups: 40 patients with DR, and 40 healthy controls. Ophthalmic examinations, biochemical measurements, and assessments of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and Montgomery and Asberg Depression Rating Scale (MADRS) were performed.
Results: Results indicated that patients with DR had significantly higher levels of anxiety and depression compared to controls. The study found no significant correlation between HADS and MADRS scores with patients' gender, type of therapy, or the type of DR. However, a higher HADS and MADRS score was observed in patients with left-side OCT macular edema.
Conclusions: The study highlights the complex interaction between psychiatric disorders and somatic illnesses, emphasizing the need for comprehensive care strategies that address both physical and mental health to improve patient outcomes.
目的:糖尿病视网膜病变(Diabetic retinopathy, DR)是糖尿病(diabetes mellitus, DM)的一种严重并发症,可导致视力丧失和失明,通常发生在DM诊断后12-20年。焦虑和抑郁常与DM和DR等慢性疾病共同发生,影响其发病、病程和预后。本研究旨在探讨焦虑、抑郁、DR和黄斑变化之间的联系。方法:在塞尔维亚尼什大学临床中心眼科诊所进行横断面研究,80名成人参与者naïve接受精神病学和侵入性眼科治疗,分为两组:40名DR患者和40名健康对照组。采用医院焦虑抑郁量表(HADS)和Montgomery and Asberg抑郁评定量表(MADRS)进行眼科检查、生化测量和焦虑抑郁评估。结果:结果表明,DR患者的焦虑和抑郁水平明显高于对照组。研究发现HADS和MADRS评分与患者的性别、治疗类型或dr类型没有显著相关性。然而,左侧OCT黄斑水肿患者的HADS和MADRS评分较高。结论:该研究强调了精神疾病和躯体疾病之间复杂的相互作用,强调需要综合护理策略来解决身体和心理健康问题,以改善患者的预后。
{"title":"Linking diabetic retinal changes with the occurrence of anxiety and depression in working population.","authors":"Sonja P Cekić, Dijana S Risimić, Maja M Simonović, Nikola M Stojanović, Aleksandra Ignjatović","doi":"10.1515/med-2026-1377","DOIUrl":"10.1515/med-2026-1377","url":null,"abstract":"<p><strong>Objectives: </strong>Diabetic retinopathy (DR) is a severe complication of diabetes mellitus (DM) leading to vision loss and blindness, which typically develops 12-20 years after the diagnosis of DM. Anxiety and depression frequently co-occur with chronic medical conditions like DM and DR, impacting their onset, course, and prognosis. This study aimed to examine the link between anxiety, depression, DR, and macular changes.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at the Clinic for Ophthalmology, University Clinical Center Niš, Serbia, involving 80 adult participants, naïve to psychiatric and invasive ophthalmological therapy, divided into two groups: 40 patients with DR, and 40 healthy controls. Ophthalmic examinations, biochemical measurements, and assessments of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and Montgomery and Asberg Depression Rating Scale (MADRS) were performed.</p><p><strong>Results: </strong>Results indicated that patients with DR had significantly higher levels of anxiety and depression compared to controls. The study found no significant correlation between HADS and MADRS scores with patients' gender, type of therapy, or the type of DR. However, a higher HADS and MADRS score was observed in patients with left-side OCT macular edema.</p><p><strong>Conclusions: </strong>The study highlights the complex interaction between psychiatric disorders and somatic illnesses, emphasizing the need for comprehensive care strategies that address both physical and mental health to improve patient outcomes.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261377"},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12962732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-02eCollection Date: 2026-01-01DOI: 10.1515/med-2026-1394
Carla Cristina Nunes Teixeira Veiga, Paulo Alexandre Oliveira Marques, José Manuel Monteiro Dias, Amâncio António de Sousa Carvalho
Objectives: Delirium is a common but frequently underdiagnosed complication in adult intensive care units (ICU), associated with increased morbidity, mortality, and healthcare costs. Early detection using validated tools is essential. This study aim to translate, adapt, and validate the Confusion Assessment Method for Intensive Care Units flowsheet (CAM-ICU flowsheet) into European Portuguese.
Methods: A methodological, cross-sectional, descriptive-correlational study was conducted in a northern Portuguese ICU. The CAM-ICU flowsheet was translated and back-translated, followed by expert validation. Forty-two adult ICU patients on invasive mechanical ventilation were assessed using the adapted tool by two trained observers. Diagnostic accuracy was evaluated using DSM-5 criteria as the gold standard. Statistical analysis included sensitivity, specificity, kappa coefficient, and ROC curves.
Results: Delirium was detected in 57.1 % of patients. The CAM-ICU flowsheet in European Portuguese demonstrated high interobserver agreement (κ=0.952), excellent sensitivity (100 %), and specificity (81.8-86.3 %). ROC AUC ranged from 0.909 to 0.932. The inattentiveness feature was the core for the presence or absence of delirium.
Conclusions: The CAM-ICU flowsheet in European Portuguese was validated to assess delirium in nonverbal ICU patients on mechanical ventilation through this study and demonstrated to be a reliable and valid tool.
{"title":"Validation of the confusion assessment method for intensive care.","authors":"Carla Cristina Nunes Teixeira Veiga, Paulo Alexandre Oliveira Marques, José Manuel Monteiro Dias, Amâncio António de Sousa Carvalho","doi":"10.1515/med-2026-1394","DOIUrl":"10.1515/med-2026-1394","url":null,"abstract":"<p><strong>Objectives: </strong>Delirium is a common but frequently underdiagnosed complication in adult intensive care units (ICU), associated with increased morbidity, mortality, and healthcare costs. Early detection using validated tools is essential. This study aim to translate, adapt, and validate the Confusion Assessment Method for Intensive Care Units flowsheet (CAM-ICU flowsheet) into European Portuguese.</p><p><strong>Methods: </strong>A methodological, cross-sectional, descriptive-correlational study was conducted in a northern Portuguese ICU. The CAM-ICU flowsheet was translated and back-translated, followed by expert validation. Forty-two adult ICU patients on invasive mechanical ventilation were assessed using the adapted tool by two trained observers. Diagnostic accuracy was evaluated using DSM-5 criteria as the gold standard. Statistical analysis included sensitivity, specificity, kappa coefficient, and ROC curves.</p><p><strong>Results: </strong>Delirium was detected in 57.1 % of patients. The CAM-ICU flowsheet in European Portuguese demonstrated high interobserver agreement (κ=0.952), excellent sensitivity (100 %), and specificity (81.8-86.3 %). ROC AUC ranged from 0.909 to 0.932. The inattentiveness feature was the core for the presence or absence of delirium.</p><p><strong>Conclusions: </strong>The CAM-ICU flowsheet in European Portuguese was validated to assess delirium in nonverbal ICU patients on mechanical ventilation through this study and demonstrated to be a reliable and valid tool.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261394"},"PeriodicalIF":1.6,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12952290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147348858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-25eCollection Date: 2026-01-01DOI: 10.1515/med-2025-1367
Wei Yang, Sumin Sui, Sheng Hao
Objectives: Congenital acute megakaryoblastic leukemia (AMKL) is an extremely rare and aggressive malignancy with poor prognosis.
Case presentation: We report a female neonate with Down syndrome (DS) who presented with respiratory distress and hepatomegaly at birth. Laboratory evaluation revealed hyperleukocytosis (253.45 × 109/L) and bone marrow studies confirmed AMKL with trisomy 21. Remarkably, spontaneous hematologic remission occurred within 2 months without chemotherapy.
Conclusions: This case highlights the unique clinical course of DS-associated AMKL and underscores the potential for spontaneous regression in congenital leukemia.
{"title":"Spontaneous remission of congenital acute megakaryoblastic leukemia in a neonate with down syndrome.","authors":"Wei Yang, Sumin Sui, Sheng Hao","doi":"10.1515/med-2025-1367","DOIUrl":"https://doi.org/10.1515/med-2025-1367","url":null,"abstract":"<p><strong>Objectives: </strong>Congenital acute megakaryoblastic leukemia (AMKL) is an extremely rare and aggressive malignancy with poor prognosis.</p><p><strong>Case presentation: </strong>We report a female neonate with Down syndrome (DS) who presented with respiratory distress and hepatomegaly at birth. Laboratory evaluation revealed hyperleukocytosis (253.45 × 10<sup>9</sup>/L) and bone marrow studies confirmed AMKL with trisomy 21. Remarkably, spontaneous hematologic remission occurred within 2 months without chemotherapy.</p><p><strong>Conclusions: </strong>This case highlights the unique clinical course of DS-associated AMKL and underscores the potential for spontaneous regression in congenital leukemia.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20251367"},"PeriodicalIF":1.6,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12949609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To develop a comprehensive understanding of psychological distress and associated sociocultural and disease related factors among South Asian Individuals with COPD.
Methods: A convergent mixed methods study was used. The quantitative sample included 408 and qualitative sample included 22 individuals (11 patients and 11 family caregivers). Hospital Anxiety and Depression Scale was used for quantitative data collection and semi-structured interviews for qualitative phase. Descriptive and regression analyses were used for quantitative data and reflexive thematic analysis for qualitative data. Qualitative and quantitative data were integrated using merging integration procedure and statistics-theme joint display.
Results: The mean depression score was 10.91 ± 2.42 and the anxiety score was 9.91 ± 2.69. Quantitative and qualitative integrated data showed that factors affecting psychological distress included sex, education level, primary decision maker in the household, years of living with COPD, financial constraints, fears of the future, self-care struggles, interrupted family decision-making process, and relational support.
Conclusions: Individuals with COPD reported moderate to high levels of psychological distress influenced by societal, family, and disease related factors. Community based programs are also needed for providing adequate mental health and counselling resources to patients and their family caregivers.
{"title":"Psychological distress and associated factors among South Asian individuals with chronic obstructive pulmonary disease: a convergent mixed methods study.","authors":"Hussan Zeb, Ahtisham Younas, Angela Durante, Ercole Vellone","doi":"10.1515/med-2026-1384","DOIUrl":"https://doi.org/10.1515/med-2026-1384","url":null,"abstract":"<p><strong>Objectives: </strong>To develop a comprehensive understanding of psychological distress and associated sociocultural and disease related factors among South Asian Individuals with COPD.</p><p><strong>Methods: </strong>A convergent mixed methods study was used. The quantitative sample included 408 and qualitative sample included 22 individuals (11 patients and 11 family caregivers). Hospital Anxiety and Depression Scale was used for quantitative data collection and semi-structured interviews for qualitative phase. Descriptive and regression analyses were used for quantitative data and reflexive thematic analysis for qualitative data. Qualitative and quantitative data were integrated using merging integration procedure and statistics-theme joint display.</p><p><strong>Results: </strong>The mean depression score was 10.91 ± 2.42 and the anxiety score was 9.91 ± 2.69. Quantitative and qualitative integrated data showed that factors affecting psychological distress included sex, education level, primary decision maker in the household, years of living with COPD, financial constraints, fears of the future, self-care struggles, interrupted family decision-making process, and relational support.</p><p><strong>Conclusions: </strong>Individuals with COPD reported moderate to high levels of psychological distress influenced by societal, family, and disease related factors. Community based programs are also needed for providing adequate mental health and counselling resources to patients and their family caregivers.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"21 1","pages":"20261384"},"PeriodicalIF":1.6,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12949628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}